The US and EU Regulatory Perspectives on the Clinical Use of Hematopoietic Stem/Progenitor Cells Genetically Modified Ex Vivo by Retroviral Vectors.
- Resource Type
- Article
- Source
- Genetic Modification of Hematopoietic Stem Cells; 2009, p477-488, 12p
- Subject
- Language